Meritage Group LP Has Lifted Its Moodys (MCO) Holding; Zoetis Inc. (ZTS) Covered By 16 Bulls

February 17, 2018 - By Winifred Garcia

Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Zoetis Inc had 74 analyst reports since July 24, 2015 according to SRatingsIntel. BMO Capital Markets upgraded the stock to “Outperform” rating in Friday, September 11 report. The firm has “Buy” rating given on Thursday, February 15 by Cowen & Co. Cowen & Co maintained the stock with “Buy” rating in Monday, July 10 report. The stock of Zoetis Inc. (NYSE:ZTS) has “Buy” rating given on Friday, November 3 by Piper Jaffray. Cowen & Co upgraded Zoetis Inc. (NYSE:ZTS) on Thursday, December 15 to “Outperform” rating. Piper Jaffray maintained the shares of ZTS in report on Friday, August 25 with “Buy” rating. The rating was initiated by Deutsche Bank on Tuesday, December 20 with “Buy”. The stock has “Overweight” rating by Cantor Fitzgerald on Friday, June 16. Cantor Fitzgerald maintained Zoetis Inc. (NYSE:ZTS) rating on Thursday, December 21. Cantor Fitzgerald has “Buy” rating and $85.0 target. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 20. See Zoetis Inc. (NYSE:ZTS) latest ratings:

16/02/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Hold Old Target: $76 New Target: $78 Maintain
16/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $88.0 Maintain
15/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $86.0 Maintain
15/02/2018 Broker: Cowen & Co Rating: Buy New Target: $85.0 Maintain
13/02/2018 Broker: Barclays Capital Rating: Hold New Target: $71.0
16/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $84.0 Maintain
16/01/2018 Broker: Jefferies Rating: Buy New Target: $89.0 Maintain
04/01/2018 Broker: Citigroup Rating: Buy New Target: $85.0 Upgrade
02/01/2018 Broker: Craig Hallum Rating: Buy New Target: $85.0 Maintain
21/12/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $85.0 Maintain

Meritage Group Lp increased Moodys Corp (MCO) stake by 22.92% reported in 2017Q3 SEC filing. Meritage Group Lp acquired 225,432 shares as Moodys Corp (MCO)’s stock rose 1.64%. The Meritage Group Lp holds 1.21 million shares with $168.31M value, up from 983,609 last quarter. Moodys Corp now has $32.15B valuation. The stock increased 1.00% or $1.66 during the last trading session, reaching $168.21. About 765,635 shares traded. Moody's Corporation (NYSE:MCO) has risen 23.29% since February 17, 2017 and is uptrending. It has outperformed by 6.59% the S&P500.

Investors sentiment increased to 1.1 in Q3 2017. Its up 0.06, from 1.04 in 2017Q2. It improved, as 41 investors sold Zoetis Inc. shares while 233 reduced holdings. 62 funds opened positions while 240 raised stakes. 440.74 million shares or 0.80% less from 444.27 million shares in 2017Q2 were reported. Victory Mgmt invested 0.04% in Zoetis Inc. (NYSE:ZTS). Ibm Retirement Fund invested in 0.16% or 12,342 shares. Verition Fund Mngmt Ltd Company stated it has 23,923 shares. Cipher Capital Limited Partnership reported 79,319 shares. Foundry Ptnrs Limited Liability Com stated it has 10,263 shares. Rhumbline Advisers reported 0.15% of its portfolio in Zoetis Inc. (NYSE:ZTS). Citigroup Inc invested in 517,615 shares. Bp Public Limited Liability Co stated it has 132,000 shares or 0.3% of all its holdings. Brown Advisory holds 7.06M shares or 1.49% of its portfolio. Friess Ltd Liability Company stated it has 310,190 shares or 1.73% of all its holdings. Ing Groep Nv has 0.02% invested in Zoetis Inc. (NYSE:ZTS) for 17,252 shares. 47,982 are owned by Blb&B Ltd Com. 5.36M were reported by Cantillon Cap Mngmt Ltd Co. Moors Cabot stated it has 15,669 shares or 0.14% of all its holdings. Northern Tru Corporation holds 0.1% or 5.84M shares in its portfolio.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. The company has market cap of $38.85 billion. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. It has a 45.56 P/E ratio. The firm also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products.

The stock increased 1.57% or $1.23 during the last trading session, reaching $79.73. About 3.96 million shares traded or 57.94% up from the average. Zoetis Inc. (NYSE:ZTS) has risen 29.89% since February 17, 2017 and is uptrending. It has outperformed by 13.19% the S&P500.

Among 14 analysts covering Moody’s (NYSE:MCO), 3 have Buy rating, 0 Sell and 11 Hold. Therefore 21% are positive. Moody’s had 50 analyst reports since October 5, 2015 according to SRatingsIntel. Stifel Nicolaus initiated it with “Hold” rating and $167.0 target in Tuesday, December 19 report. Barclays Capital maintained the shares of MCO in report on Friday, April 28 with “Hold” rating. The firm has “Buy” rating by Nomura given on Thursday, January 11. Cantor Fitzgerald maintained the stock with “Neutral” rating in Monday, February 12 report. The stock of Moody's Corporation (NYSE:MCO) earned “Neutral” rating by Atlantic Securities on Wednesday, October 14. As per Tuesday, July 11, the company rating was maintained by BMO Capital Markets. The stock of Moody's Corporation (NYSE:MCO) earned “Neutral” rating by UBS on Friday, August 18. The stock has “Hold” rating by Piper Jaffray on Wednesday, October 4. The stock has “Hold” rating by Wells Fargo on Monday, February 12. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, July 25.

Investors sentiment increased to 1.01 in Q3 2017. Its up 0.03, from 0.98 in 2017Q2. It improved, as 18 investors sold MCO shares while 182 reduced holdings. 65 funds opened positions while 137 raised stakes. 158.15 million shares or 1.61% less from 160.75 million shares in 2017Q2 were reported. Dubuque Bank & Trust And Co holds 1,400 shares or 0.03% of its portfolio. Epoch Inv Prtnrs invested in 0.01% or 23,208 shares. Private Advisor Gp Inc Ltd Liability accumulated 1,470 shares. Agf Investments America invested 2.18% of its portfolio in Moody's Corporation (NYSE:MCO). Eqis Cap Mgmt owns 3,339 shares or 0.03% of their US portfolio. Cwm Ltd Liability Company owns 41 shares. Wetherby Asset Mgmt has invested 0.09% in Moody's Corporation (NYSE:MCO). Hm Payson & reported 69,811 shares. Hartford Inv Mgmt Com, a Connecticut-based fund reported 48,478 shares. Cambridge Trust reported 0.61% in Moody's Corporation (NYSE:MCO). Ferguson Wellman Capital Mngmt invested 0.04% in Moody's Corporation (NYSE:MCO). Covington Cap reported 1,940 shares. Bryn Mawr Tru holds 0.05% or 5,879 shares in its portfolio. Jnba holds 0.01% in Moody's Corporation (NYSE:MCO) or 310 shares. Windacre Partnership Llc owns 13.01% invested in Moody's Corporation (NYSE:MCO) for 660,000 shares.

Since September 7, 2017, it had 0 insider buys, and 4 selling transactions for $16.24 million activity. Shares for $69,205 were sold by Duffie Darrell. Another trade for 45,216 shares valued at $6.07M was made by MCDANIEL RAYMOND W on Thursday, September 7. Fauber Robert also sold $808 worth of Moody's Corporation (NYSE:MCO) shares. Another trade for 62,500 shares valued at $10.11M was made by Almeida Mark on Wednesday, November 22.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: